4 Amendments of Biljana BORZAN related to 2020/0102(COD)
Amendment 272 #
Proposal for a regulation
Recital 18
Recital 18
(18) The Programme therefore should contribute to disease prevention throughout the lifetime of an individual and to health promotion by addressing health risk factorscommercial determinants of health, such as the use of tobacco and related products and exposure to their emissions, the harmful use of alcohol,alcohol use, the unhealthy food environment and the consumption of illicit drugs and psychoactive substances. The Programme should also contribute to the reduction of drugs-related health damage, obesity and unhealthy dietary habits and, physical inactivity, and exposure to environmental pollution, and foster health supportive environments for healthy lifestyles in order to complement Member States action in these areas. The Programme therefore should contribute to a high level of human health protection and prevention, throughout the entire lifetime of an individual, including through the promotion of physical activity, nutritional care and promotion of health education. The Programme should also strengthen and support EU health related legislation, including in the area of environmental health, and foster Health in All Policies. The Programme should also therefore contribute to the objectives of the European Green Deal, the Farm to Fork Strategy and the Biodiversity Strategy.
Amendment 437 #
Proposal for a regulation
Article 2 – paragraph 1 – point 10 a (new)
Article 2 – paragraph 1 – point 10 a (new)
(10a) ‘Commercial determinant of health’ means commercial strategies and approaches used to promote products and choices that are detrimental to health.
Amendment 563 #
Proposal for a regulation
Article 4 – paragraph 1 – point 6
Article 4 – paragraph 1 – point 6
(6) support action, including policy, for the surveillance, prevention, diagnosis and treatment and care of non- communicable diseases, and notably of cancer by providing a European strategic Chronic disease framework to support Member States action addressing the commercial determinants of health;
Amendment 952 #
Proposal for a regulation
Annex I – point i – point v a (new)
Annex I – point i – point v a (new)
(v a) Support actions to implement models of R&D and IP ownership and management which prioritize the public interest and guarantee societal benefit, for example by including binding safeguards to ensure availability, accessibility and affordability of medical products developed with public funds;